Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the Lentiviral Vector market grown over the years?

In recent years, the size of the lentiviral vector market has seen significant expansion. By 2024, it is expected to increase from $14.37 billion to $16.62 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.7%. This growth during the historic period is likely due to the rise in genetic disorders, the need for gene delivery, expansion in biotech and pharmaceutical sectors, investment in clinical trials, and receiving regulatory approvals.

What Is the forecasted market size and growth rate for the lentiviral vector market?

In the upcoming years, the lentiviral vector market is predicted to witness a swift expansion. The market size is expected to reach $29.41 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 15.3%. This progression in the forecasted phase can be linked to various factors such as the surge in personalized medicinal care, advancements in gene editing, the rising demand for therapy for rare diseases, the utilization of lentiviral vector, funding for genomic medicine, and an intensified focus on manufacturing scalability. Some of the key trends anticipated during this period are an extension of research and development, integration of lentiviral vectors in CAR-T cell therapy, the evolution of next-generation vectors, its use in vaccine creation, and the advancement of production technologies.

Get your lentiviral vector market report here!

https://www.thebusinessresearchcompany.com/report/lentiviral-vector-global-market-report

What are the major factors driving growth in the lentiviral vector market?

The rise in chronic diseases is anticipated to fuel growth in the lentiviral vectors market. Chronic maladies are prolonged medical issues that typically develop gradually and often persist throughout a person’s life. The growth in chronic diseases is driven by aging populations, unhealthy lifestyles, urbanization, and environmental factors. By delivering effective and versatile tools for creating vaccines and formulating treatments for chronic diseases, lentiviral vectors are able to tackle unmet medical needs and enhance patient results. As an illustration, the British Heart Foundation, a UK-based cardiovascular research charity, indicated in September 2024 that roughly 7.6 million individuals in the UK suffer from heart and circulatory ailments, with an estimated 4 million males and 3.6 million females affected. These conditions account for approximately 27% of all fatalities in the UK, representing over 170,000 deaths per year, or approximately 480 deaths daily. This equates to one death every three minutes. Consequently, the escalating prevalence of chronic diseases is bolstering the expansion of the lentiviral vectors market.

What key areas define the segmentation of the global lentiviral vector Market?

The lentiviral vector market covered in this report is segmented –

1) By Product Type: Kits, Reagents And Consumables

2) By Indication: Cancer, Genetic Disorder, Infectious Disease, Veterinary Disease, Other Indications

3) By End User: Biotechnology Companies, Pharmaceutical Companies, Contract Research Organization (CRO), Academic And Research Institutes

Subsegments:

1) By Kits: Lentiviral Transduction Kits, Lentiviral Packaging Kits, Lentiviral Vector Production Kits

2) By Reagents and Consumables: Lentiviral Packaging Reagents, Lentiviral Vector Concentration Reagents, Transfection Reagents for Lentiviral Vectors

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14742&type=smp

What are the top market players propelling the growth of the lentiviral vector industry?

Major companies operating in the lentiviral vector market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Agilent Technologies Inc., Amgen Inc., Merck KGaA, Lonza Group Ag, Cytiva, Charles River Laboratories, Bio-Rad Laboratories Inc., Promega Corporation, Takara Bio Inc., Sino Biological Inc., OriGene Technologies Inc., Applied Biological Materials Inc., Oxford Biomedica, Sirion-Biotech GmbH, Yposkesi

What are the key trends shaping the future of the lentiviral vector market?

Key players in the lentiviral vectors market are concentrating on the creation of LV vector production platforms, including LentiSure, to improve the robustness and efficiency of lentivirus vector production for cell-based immuno-oncology treatments. The LentiSure platform is specifically designed for the production of lentiviral vectors used in these therapies, with an emphasis on enhanced efficiency and robust vector generation. In May 2023, for example, Yposkesi sk pharmteco, a viral vector manufacturer based in France, introduced LentiSure. This innovative platform is created to improve lentiviral (LV) vector production, with a primary goal of bolstering efficiency and resilience in lentivirus production. The platform is a response to the increasing need for durable and economically scalable viral-vector manufacturing technologies for cell and gene therapies. It provides consistent product quality, with average titers of 10e7 IG/mL bioreactor volume at cell culture harvest, ensuring greater productivity and success for developers of cell therapy.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14742

What regions are dominating the lentiviral vector market growth?

North America was the largest region in the lentiviral vector market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lentiviral vector market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Torque Vectoring Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/torque-vectoring-global-market-report

Viral Vector Manufacturing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/viral-vector-manufacturing-global-market-report

Vector Database Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/vector-database-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: